Micro-Albumin Rapid Test Device (Urine)

Micro-albumin testing helps detect small amounts of albumin in urine. Albumin is a protein normally found in blood, and only very small amounts should pass into urine when kidneys are healthy. Higher urinary albumin levels may be an early warning sign of kidney damage or kidney disease.

• The Micro-Albumin Rapid Test Device is important because albumin leakage into urine can appear before serious symptoms develop.
• Patients with diabetes or hypertension may benefit from periodic urine microalbumin screening because these conditions are strongly linked with kidney complications.
• The test may help support early kidney risk screening and routine preventive healthcare programs.
• Regular urine microalbumin testing can help healthcare professionals identify risk earlier and recommend confirmatory testing when needed.

The ALB rapid test by LARKSOIS Pharma may be used in professional diagnostic and healthcare screening environments.

Applications

• Early kidney risk screening
• Diabetes-related kidney monitoring
• Hypertension-related kidney health evaluation
• Routine preventive health checkups
• Follow-up testing support
• Community screening programs
• Hospital and laboratory urine testing
• Point-of-care diagnostic workflows
• International healthcare screening programs

• The ALB rapid test works by detecting microalbumin present in urine.
• A urine sample is applied to the test device according to the instructions for use.
• The rapid test format simplifies screening and reduces waiting time compared with conventional laboratory workflows.
• Healthcare professionals may use the Micro-Albumin Rapid Test Device (Urine) as an initial screening tool before confirmatory testing.

The Micro-Albumin Rapid Test Device uses rapid urine-based testing technology for detection of microalbumin in human urine samples.

Benefits

• Rapid urine-based detection
• Simple test procedure
• Suitable for point-of-care screening
• No complex laboratory setup required for rapid format
• Supports early kidney health assessment
• Useful for diabetic and hypertensive patient screening
• Compact device format
• Professional diagnostic quality

The Micro-Albumin Rapid Test Device is designed for human urine specimens. Correct specimen collection and handling are important for reliable test performance.

Guidance

• Use approved urine specimens only
• Collect specimens according to the product insert
• Use clean sample collection containers
• Avoid contaminated or improperly stored samples
• Apply urine sample correctly to the test device
• Read results only within the recommended time window
• Handle urine specimens according to laboratory safety procedures
• Follow all instructions for use carefully

Note

Specimen collection, handling, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Micro-Albumin Rapid Test Device by LARKSOIS Pharma is designed for detection of microalbumin in urine samples. Detection of elevated microalbumin may support kidney function screening, diabetic kidney monitoring, and renal health assessment.

• Microalbumin in urine may be an early indicator of diabetic kidney involvement.
• High blood pressure can affect kidney function over time, making urine microalbumin testing useful for at-risk patients.
• Clinics and laboratories may use the Micro-Albumin Rapid Test Device (Urine) for quick screening before confirmatory testing.
• The test may support preventive health checkups, wellness programs, and international healthcare screening workflows.

The Micro-Albumin Rapid Test Device is a screening aid and should not be used as the only basis for diagnosis. Results should be interpreted with symptoms, medical history, clinical findings, and additional laboratory testing.

Instructions

• The test does not confirm a final diagnosis
• Abnormal results may require repeat or confirmatory kidney tests
• Temporary albumin elevation may occur due to fever, inflammation, intense exercise, urinary tract infection, or certain medications
• Incorrect specimen handling may affect results
• False positive or false negative results may occur
• The test is intended for professional diagnostic use only
• Results should be interpreted with clinical findings
• Follow the official product insert carefully

Instructions

• Rapid urine-based detection
• Simple test procedure
• Suitable for point-of-care screening
• Supports early kidney health assessment
• Useful for diabetic and hypertensive patient screening
• Compact rapid test format
• Professional diagnostic quality
• Suitable for international healthcare markets

Note

The Micro-Albumin Rapid Test Device by LARKSOIS Pharma is designed for professional and convenient diagnostic use.

Steps

• Bring the test device and urine sample to room temperature
• Remove the test cassette from the sealed pouch
• Collect a clean urine specimen according to instructions
• Apply the urine sample to the test device as instructed
• Wait for the recommended reaction time
• Interpret the result according to the product insert
• Read results only within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

Microalbumin is detected above the test threshold and may require medical evaluation or confirmatory kidney testing.

Negative

Microalbumin level is within expected range or below the test detection threshold.

Invalid

Test procedure may be incorrect or device failure may have occurred. Repeat testing with a new device is recommended.

Instructions

• Store the Micro-Albumin Rapid Test Device according to label instructions
• Store in a cool and dry place
• Keep away from direct sunlight
• Do not freeze
• Use before expiry date
• Keep sealed until use
• Use only clean urine samples
• Follow the instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle urine specimens carefully
• Wear gloves during sample handling
• Do not reuse the test device
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm abnormal results with clinical evaluation when required

LARKSOIS Pharma focuses on internationally acceptable diagnostic quality, reliable packaging, and consistent product performance. The ALB rapid test is developed for professional diagnostic environments where speed, simplicity, and accessibility are important.

Advantages

• International diagnostic product range
• Reliable urine rapid test solutions
• Professional healthcare supply support
• Quality-focused product development
• Suitable for hospitals, labs, and distributors
• Export-ready product positioning
• Strong focus on affordable healthcare access